Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
ABPI Welcomes Amended Legislation On Curbing Excessive Unbranded Drug Prices
May 05 2017
•
By
Francesca Bruce
ABPI has wecomed new legislation to curb excessive pricing
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from United Kingdom
More from Europe